BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11200144)

  • 1. Developments in the treatment of gastric cancer in Europe.
    Köhne CH; Wils JA; Wilke HJ
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):22-5. PubMed ID: 11200144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Latest progress on chemotherapy for advanced gastric cancer].
    Tahara M; Ohtsu A
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2048-58. PubMed ID: 11103236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for advanced gastric cancer.
    Wagner AD; Unverzagt S; Grothe W; Kleber G; Grothey A; Haerting J; Fleig WE
    Cochrane Database Syst Rev; 2010 Mar; (3):CD004064. PubMed ID: 20238327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel-based chemotherapy in the treatment of gastric cancer.
    Roth AD; Ajani J
    Ann Oncol; 2003; 14 Suppl 2():ii41-4. PubMed ID: 12810457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine-based combination treatment of pancreatic cancer.
    Heinemann V
    Semin Oncol; 2002 Feb; 29(1 Suppl 3):25-35. PubMed ID: 11894005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
    Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advances in chemotherapy for digestive cancers with special references to gastric and colonic cancers].
    Sawabu N
    Nihon Shokakibyo Gakkai Zasshi; 2003 Jun; 100(6):645-52. PubMed ID: 12833857
    [No Abstract]   [Full Text] [Related]  

  • 8. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irinotecan in the treatment of gastric cancer.
    Bugat R
    Ann Oncol; 2003; 14 Suppl 2():ii37-40. PubMed ID: 12810456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel in combination with fluorouracil for advanced solid tumors.
    Burris HA
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study.
    Constenla M; Garcia-Arroyo R; Lorenzo I; Carrete N; Campos B; Palacios P
    Gastric Cancer; 2002; 5(3):142-7. PubMed ID: 12378340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.
    Thuss-Patience PC; Kretzschmar A; Krenn V; Dörken B; Reichardt P
    Onkologie; 2003 Feb; 26(1):63-5. PubMed ID: 12624520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine for the treatment of gastric cancer.
    Kim TY; Oh DY; Bang YJ
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1471-81. PubMed ID: 26470733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan-based combinations for the adjuvant treatment of stage III colon cancer.
    Saltz L
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):47-50. PubMed ID: 11200149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy for gastric cancer].
    Baba H; Kakeji Y; Oki E; Tokunaga E; Ushiro S; Watanabe M; Maehara Y
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1881-8. PubMed ID: 14650954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European experience of docetaxel and cisplatin in advanced gastric cancer.
    Roth AD
    Gastric Cancer; 2002; 5 Suppl 1():27-9. PubMed ID: 12772884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptothecin and taxane regimens for small-cell lung cancer.
    Kwong MS; Bleickardt E; Murren JR
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 9):33-8. PubMed ID: 12375799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New combination therapies for gastrointestinal cancer].
    Sasaki T; Maeda Y; Kobayashi T; Okamoto R; Omuro Y; Takeda N
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):348-55. PubMed ID: 10740627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified docetaxel-cisplatin in combination with capecitabine as first-line treatment in metastatic gastric cancer. a phase II study.
    Polyzos A; Felekouras E; Karatzas T; Griniatsos J; Dimitroulis D; Polyzos K; Kontzoglou K; Mantas D; Karavokyros J; Nikiteas N; Tsavaris N; Syrigos K; Vafiadis I
    Anticancer Res; 2012 Sep; 32(9):4151-6. PubMed ID: 22993377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cisplatin-5-fluorouracil-folinic acid versus modified docetaxel-cisplatin-5-fluorouracil regimens in the first-line treatment of metastatic gastric cancer.
    Kos FT; Uncu D; Ozdemir N; Budakoglu B; Odabaş H; Abali H; Oksuzoglu B; Aksoy S; Zengin N
    Chemotherapy; 2011; 57(3):230-5. PubMed ID: 21597287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.